Characterization of an MR-compatible motion platform for quality assurance of motion-compensated treatments on the 1.5 T MR-linac

被引:1
作者
Oolbekkink, Stijn [1 ]
Borman, Pim T. S. [1 ]
Wolthaus, Jochem W. H. [1 ]
van Asselen, Bram [1 ]
van Lier, Astrid L. H. M. W. [1 ]
Dunn, Stephanie [2 ]
Koenig, Grant R. [2 ]
Hartman, Nick [2 ]
Kheirkhah, Niusha [2 ]
Raaymakers, Bas W. [1 ]
Fast, Martin F. [1 ]
机构
[1] Univ Med Ctr Utrecht, Dept Radiotherapy, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands
[2] Modus Med Devices Inc, IBA QUASAR, London, ON, Canada
基金
荷兰研究理事会;
关键词
motion-included dosimetry; MR-linac; quality assurance; RADIOTHERAPY; MANAGEMENT;
D O I
10.1002/mp.17632
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
BackgroundNovel motion-compensated treatment techniques on the MR-linac can address adverse intra-fraction motion effects. These techniques involve beam gating or intra-fraction adaptations of the treatment plan based on real-time magnetic resonance imaging (MRI) performed during treatment. For quality assurance (QA) of these workflows, a multi-purpose motion platform is desirable. This platform should accommodate various phantoms, enabling multiple QA workflows.PurposeThis study aims to evaluate the new IBA QUASAR Motion MR Platform for use in the 1.5 T MR-linac.MethodsThe motion platform was assessed for several magnetic resonance (MR) characteristics, including spurious noise generation and B0&B1 homogeneity. In addition, the motion platform's motion accuracy and beam attenuation were assessed. An application was shown with a ScandiDos Delta4 Phantom+ MR demonstrating patient-specific plan QA of gated treatments using time-resolved dosimetry that includes motion based on a patient's respiratory motion trace.ResultsAll MR characterization measurements were within the set tolerances for MRI QA. The motion platform motion accuracy showed excellent agreement with the reference, with a standard deviation of the amplitude of 0.01 mm (20 kg load) for the motor's self-estimated positions and 0.22 mm (no load) for the images acquired with the electronic portal imager. Beam attenuation was found to be 11.8%. The combination of the motion platform and Delta4 demonstrated motion-included dosimetry at high temporal and spatial resolutions. Motion influenced the measured dose in non-gated treatments by up to -20.1%, while gated deliveries showed differences of up to -1.7% for selected diodes.ConclusionThe motion platform was found to be usable in a 1.5 T magnetic field, and for all MR characterization experiments, no influence from the motion platform was observed. This motion platform enables to perform motion-included QA, with a measurement device of choice.
引用
收藏
页数:7
相关论文
共 21 条
[1]  
American College of Radiology, 2000, MRI quality control manual
[2]  
[Anonymous], 1998, Phantom test guidance for the ACR MRI Accreditation Program
[3]   Emerging role of MRI in radiation therapy [J].
Chandarana, Hersh ;
Wang, Hesheng ;
Tijssen, R. H. N. ;
Das, Indra J. .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2018, 48 (06) :1468-1478
[4]  
De Vries JHW., 2018, PHYS MED BIOL, V63, P1
[5]   Intrafraction Motion Management With MR-Guided Radiation Therapy [J].
Fast, Martin F. ;
Cao, Minsong ;
Parikh, Parag ;
Sonke, Jan-Jakob .
SEMINARS IN RADIATION ONCOLOGY, 2024, 34 (01) :92-106
[6]   Reducing PTV margins for prostate SBRT with motion compensation and gating techniques [J].
Goddard, Lee ;
Jeong, Kyoungkeun ;
Tang, Justin ;
Garg, Madhur ;
Tome, Wolfgang A. A. .
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2023, 24 (04)
[7]   Gating and intrafraction drift correction on a 1.5 T MR-Linac: Clinical dosimetric benefits for upper abdominal tumors [J].
Grimbergen, Guus ;
Hackett, Sara L. ;
van Ommen, Fasco ;
van Lier, Astrid L. H. M. W. ;
Borman, Pim T. S. ;
Meijers, Lieke T. C. ;
de Groot-van Breugel, Eline N. ;
de Boer, Johannes C. J. ;
Raaymakers, Bas W. ;
Intven, Martijn P. W. ;
Meijer, Gert J. .
RADIOTHERAPY AND ONCOLOGY, 2023, 189
[8]   Consequences of air around an ionization chamber: Are existing solid phantoms suitable for reference dosimetry on an MR-linac? [J].
Hackett, S. L. ;
van Asselen, B. ;
Wolthaus, J. W. H. ;
Kok, J. G. M. ;
Woodings, S. J. ;
Lagendijk, J. J. W. ;
Raaymakers, B. W. .
MEDICAL PHYSICS, 2016, 43 (07) :3961-3968
[9]   Technical design and concept of a 0.35 T MR-Linac [J].
Klueter, Sebastian .
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2019, 18 :98-101
[10]   MRI/linac integration [J].
Lagendijk, Jan J. W. ;
Raaymakers, Bas W. ;
Raaijmakers, Alexander J. E. ;
Overweg, Johan ;
Brown, Kevin J. ;
Kerkhof, Ellen M. ;
van der Put, Richard W. ;
Hardemark, Bjorn ;
van Vutpen, Marco ;
van der Heide, Uutke A. .
RADIOTHERAPY AND ONCOLOGY, 2008, 86 (01) :25-29